Skip to main content
. Author manuscript; available in PMC: 2019 Dec 25.
Published in final edited form as: J Am Coll Cardiol. 2018 Dec 25;72(25):3246–3254. doi: 10.1016/j.jacc.2018.09.076

Figure 1. Cumulative incidence of HF, CVD, and mortality by quartiles of longitudinal change in galectin-3.

Figure 1.

Longitudinal rise in Gal-3 levels was associated with significantly higher risk of developing incident HF (A), incident CVD (B), and all-cause mortality (C). CVD = cardiovascular disease, HF = heart failure.